Literature DB >> 1355104

CD4+8- thymocytes bearing major histocompatibility complex class I-restricted T cell receptors: evidence for homeostatic control of early stages of CD4/CD8 lineage development.

T Crompton1, H Pircher, H R MacDonald.   

Abstract

During thymus development CD4+ CD8+ precursor cells differentiate into mature CD4+ and CD8+ T cells expressing T cell receptors (TCR) that recognize foreign antigens in association with major histocompatibility complex (MHC) class II or I molecules, respectively. Studies with TCR transgenic mice have shown that the accumulation of mature CD4+ and CD8+ thymocytes is strongly skewed by the MHC restriction specificity of the TCR, thus suggesting that commitment of CD4+ CD8+ precursors to the CD4 or CD8 lineage is a direct consequence of TCR/MHC interactions. However, we show here that CD4+ cells expressing an inappropriate (MHC class I-specific) TCR appear transiently in the neonatal thymus of TCR transgenic mice and can also be found in the periphery of adult TCR transgenic recombination-deficient SCID mice. These data argue that the early stages of CD4 and CD8 lineage development in the thymus are (at least in part) controlled by homeostatic mechanisms independent of appropriate TCR/MHC interactions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1355104      PMCID: PMC2119344          DOI: 10.1084/jem.176.3.903

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Ontogeny of a novel CD4+CD8-CD3- thymocyte subpopulation: a comparison with CD4- CD8+ CD3- thymocytes.

Authors:  P Hugo; G A Waanders; R Scollay; K Shortman; R L Boyd
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

2.  Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice.

Authors:  M J Grusby; R S Johnson; V E Papaioannou; L H Glimcher
Journal:  Science       Date:  1991-09-20       Impact factor: 47.728

Review 3.  Developmental biology of T cells in T cell-receptor transgenic mice.

Authors:  H von Boehmer
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

4.  Characterization of cell lines expressing mutant I-Ab and I-Ak molecules allows the definition of distinct serologic epitopes on A alpha and A beta polypeptides.

Authors:  B N Beck; J M Buerstedde; C J Krco; A E Nilson; C G Chase; D J McKean
Journal:  J Immunol       Date:  1986-04-15       Impact factor: 5.422

5.  The generation of mature T cells requires interaction of the alpha beta T-cell receptor with major histocompatibility antigens.

Authors:  B Scott; H Blüthmann; H S Teh; H von Boehmer
Journal:  Nature       Date:  1989-04-13       Impact factor: 49.962

6.  Disorganization and restoration of thymic medullary epithelial cells in T cell receptor-negative scid mice: evidence that receptor-bearing lymphocytes influence maturation of the thymic microenvironment.

Authors:  E W Shores; W Van Ewijk; A Singer
Journal:  Eur J Immunol       Date:  1991-07       Impact factor: 5.532

7.  A cortisone sensitive CD3low subset of CD4+CD8- thymocytes represents an intermediate stage in intrathymic repertoire selection.

Authors:  T Crompton; P Ohashi; S D Schneider; H Pircher; H R MacDonald
Journal:  Int Immunol       Date:  1992-02       Impact factor: 4.823

8.  Preferential positive selection of V alpha 2+ CD8+ T cells in mouse strains expressing both H-2k and T cell receptor V alpha a haplotypes: determination with a V alpha 2-specific monoclonal antibody.

Authors:  H Pircher; N Rebaï; M Groettrup; C Grégoire; D E Speiser; M P Happ; E Palmer; R M Zinkernagel; H Hengartner; B Malissen
Journal:  Eur J Immunol       Date:  1992-02       Impact factor: 5.532

9.  Surface expression of a T cell receptor beta (TCR-beta) chain in the absence of TCR-alpha, -delta, and -gamma proteins.

Authors:  J A Punt; R T Kubo; T Saito; T H Finkel; S Kathiresan; K J Blank; Y Hashimoto
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

10.  Absence of the Lyt-2-,L3T4+ lineage of T cells in mice treated neonatally with anti-I-A correlates with absence of intrathymic I-A-bearing antigen-presenting cell function.

Authors:  A M Kruisbeek; J J Mond; B J Fowlkes; J A Carmen; S Bridges; D L Longo
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more
  7 in total

Review 1.  The role of CD4 in regulating homeostasis of T helper cells.

Authors:  Rolf König; Xiaoli Shen; Rosario Maroto; Timothy L Denning
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Precommitment of CD4+CD8+ thymocytes to either CD4 or CD8 lineages.

Authors:  T Crompton; R K Lees; H Pircher; H R MacDonald
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

3.  Recognition of Epstein-Barr virus (EBV)-infected cells by T cell colonies from a human chimera: restriction by allogeneic determinants.

Authors:  H Plotnicky; J L Touraine
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

4.  Thymocyte development in major histocompatibility complex-deficient mice: evidence for stochastic commitment to the CD4 and CD8 lineages.

Authors:  A L Crump; M J Grusby; L H Glimcher; H Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

5.  Both intrathymic and peripheral selection modulate the differential expression of V beta 5 among CD4+ and CD8+ T cells.

Authors:  P J Fink; K Swan; G Turk; M W Moore; F R Carbone
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

6.  Reconstitution of the subclass-specific expression of CD4 in thymocytes and peripheral T cells of transgenic mice: identification of a human CD4 enhancer.

Authors:  M D Blum; G T Wong; K M Higgins; M J Sunshine; E Lacy
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

7.  Positive selection of CD8+ T cells induced by major histocompatibility complex binding peptides in fetal thymic organ culture.

Authors:  K A Hogquist; M A Gavin; M J Bevan
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.